We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mean Platelet Volume Determines Crimean-Congo Hemorrhagic Fever Prognosis

By LabMedica International staff writers
Posted on 28 Sep 2015
Crimean-Congo hemorrhagic fever virus (CCHF), a Nairovirus within the family Bunyaviridae, causes severe disease and pancytopenia, organ failures and disseminated intravascular coagulation may occur as a result of CCHF infection.

Changes in the mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in patients that have recovered from non-fatal CCHF can be predictors for the duration of hospitalization and prognosis.

Scientists at the Recep Tayyip Erdogan University (Rize, Turkey) studied a total of 50 CCHF patients including 27 males and 23 females and a similar age group of 47 healthy individuals including 27 males and 20 females) were included in the study. More...
Hematologic and biochemical tests inclusive of C-reactive protein were conducted on patients and controls. Blood samples were checked for CCHF nucleic acids by real-time reverse transcriptase polymerase chain reaction (RT-PCR).

Biochemical tests were performed using photometric assays using the Abbott Architect c16000 analyzer (Abbott Diagnostics; Abbott Park, IL, USA). Hematological tests for hemoglobin, platelets, white blood cell counts (WBC), and MPV were performed using the Abbott Cell-Dyn Ruby analyzer. The C-reactive protein (CRP) test was performed using the nephelometric method in the Coulter Image 800 autoanalyzer (Beckman Coulter; Fullerton, CA, USA).

The MPV was statistically higher at 8.4 fL (range 6.4 to 9.4 fL) in patients than that of controls at 7.0 fL (range 6.0 to 8.7 fL). The NLR and PLR were similar in both groups. The predictors of the length of hospitalization included decreased white blood (WBC) cell and platelet counts, together with elevated prothrombin time (PT), creatinine and glucose levels. Bicytopenia and pancytopenia could also be seen in patients with CCHF. In severe cases, neutropenia and severe thrombocytopenia are also frequently encountered.

The authors concluded that the MPV was higher in patients, but NLR and PLR were similar in both groups. The MPV, NLR and PLR did not serve as predictors of hospitalization length. However, elevation of PT, creatinine, glucose, along with decreased WBC and platelets counts were found to be predictors of hospitalization period. The study was published in the September 2015 issue of Journal of Microbiology and Infectious Diseases.

Related Links:

Recep Tayyip Erdogan University
Abbott Diagnostics 
Beckman Coulter



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
Nutating Mixer
Enduro MiniMix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.